The response of chick intestine to vitamin D and its metabolites was studied in an organ culture preparation of chick ileum explants. Both 25-hydroxycholecalciferol (25-OHD3) at a concentration of 20 ng/ml or greater and 1,25-dihydroxycholecalciferol [1,25-(OH)2D3] at a concentration of 50 pg/ml or greater stimulated the rate of accumulation of [32P]phosphate and 45Ca by the explants and the incorporation of [3H]thymidine into DNA. The accumulation of [32P]phosphate by the explants was against a concentration gradient and inhibited by ouabain and dinitrophenol. Two saturable mechanisms appeared to mediate the cellular accumulation of phosphate with Ka of 0.0047 and 0.125 mM, respectively. The Vmax of the lower affinity transport mechanism was accelerated by 1,25-(OH)2D3. Actinomycin D (5.0 μg/ml) did not block the intestinal response to 1,25-(OH)2D3 stimulation of both [32p]phosphate and 45Ca accumulation. Significant stimulation of [32P]phosphate accumulation was observed 30 min after the addition of 1,25-(OH)2D3, preceding the sterol-induced increase in the rate of 45Ca uptake by 30 min and the sterol-induced increase in [3H]thymidine incorporation into DNA by 150 min. Increasing extracellular phosphate concentration to 3.0 mM increased [3H]thymidine incorporation into DNA and the rate of 45Ca uptake by the explants. Reducing extracellular phosphate concentration to 0.05 mM attenuated the response of the explants to 1,25-(OH)2D3. From these observations it is postulated that the primary action of vitamin D sterols in the intestine is to enhance the ability of the mucosal cell to accumulate phosphate. The data suggest that restoration of intracellular phosphate levels may then permit expression of the cells' response to vitamin D sterols.
Stanley J. Birge, Ruth Miller
Usage data is cumulative from November 2024 through November 2025.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 145 | 2 |
| 70 | 5 | |
| Scanned page | 281 | 6 |
| Citation downloads | 52 | 0 |
| Totals | 548 | 13 |
| Total Views | 561 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.